Angioplasty and stenting of the extracranial carotid arteries

M Henry, M Amor, C Klonaris, I Henry, I Masson, Z Chati, E Leborgne, M Hugel, M Henry, M Amor, C Klonaris, I Henry, I Masson, Z Chati, E Leborgne, M Hugel

Abstract

We performed percutaneous transluminal angioplasty and stenting in patients with carotid artery stenosis to determine the efficacy of these techniques as an alternative to surgical endarterectomy. From April 1995 through July 1999, 315 carotid angioplasty procedures were performed (right, 151; left, 164) in 290 patients ranging in age from 40 to 93 years. Of these patients, 42% were symptomatic and 58% were asymptomatic. Twenty-five patients underwent bilateral procedures. The mean percentage of stenosis was 82.3%+/-8.7% SD. Angioplasty and stenting were performed without cerebral protection in 165 arteries and with protection in 150. Two methods of protection were used: the Theron technique and the PercuSurge Guardwire temporary occlusion and aspiration system. Balloon dilation and stent placement were successful in 289 patients; in the last patient, severe arterial tortuosity prevented catheterization and stenting. We observed 13 periprocedural neurologic complications due to ischemia (4.2%): 4 transient ischemic attacks (1.3%), 4 minor strokes (1.3%), and 5 major strokes (1.6%), including 1 death. At 6 months, 210 patients had a follow-up angiogram (155) or duplex ultrasound (55). There were 10 restenoses (4.7%), 1 of which was symptomatic and 2 of which showed mild compression of a Palmaz stent without marked stenosis. Primary and secondary 4-year patency rates were 96% and 99%, respectively. These results demonstrate acceptable mortality and morbidity rates related to carotid angioplasty and stenting. However, we found the risk of embolic stroke to be substantial. Cerebral protection may improve the results of carotid angioplasty and expand the indications for this procedure.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/101050/bin/13FF1.jpg
Fig. 1 Right internal and common carotid artery stenoses.
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/101050/bin/13FF2.jpg
Fig. 2 Result after deployment of 2 Palmaz® stents: 1 in the right internal carotid artery and the 2nd in the common carotid artery.
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/101050/bin/13FF3.jpg
Fig. 3 Intracranial views showing tight stenosis of the left internal carotid artery before angioplasty.
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/101050/bin/13FF4.jpg
Fig. 4 Predilation of the left internal carotid artery lesion under cerebral protection with the PercuSurge™ device.
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/101050/bin/13FF5.jpg
Fig. 5 Final result after placement of a Palmaz® stent in the left carotid artery.

Source: PubMed

3
購読する